FDA issued a Warning Letter to Reine Lifescience on 5/9/2018 as a result of this inspection.
483 Reine Lifescience Nov 2017
483 Reine Lifescience Nov 2017
Dipesh Shah FDA$119.00 - Available NowFDA investigators audited the Reine Lifescience - Ankleshwar, India facility and issued inspectional observations (via FDA 483) on 03 Nov 2017.
Product details
- Category: Human Drugs
- Inspection end: 03 Nov 2017
- Location: Ankleshwar, India
- FEI: 3011543431
